← Back to headlines
New Study Confirms Long-Term Efficacy of HPV Vaccine
A new Swedish study has found that the HPV vaccine provides long-lasting protection against cervical cancer for at least 18 years, significantly reducing the risk.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
aftonbladetSwedish111d ago
Positiva beskedet: HPV-vaccin ger långvarigt skydd
HPV-vaccin minskar risken för livmoderhalscancer under minst 18 år. Det visar en ny svensk studie.
Read full article →svenska-dagbladetSwedish111d ago
Ny studie: HPV-vaccin ger långvarigt skydd
HPV-vaccin minskar risken för livmoderhalscancer under minst 18 år. Det visar en ny svensk studie.
Read full article →Coverage Timeline
First report: aftonbladet · 26 Feb, 04:00|Full coverage: 2 · 0m|Window: 0m
Left-leaningCenterRight-leaning
